Vitamin Shoppe Third Quarter Earnings on the Horizon

Vitamin Shoppe (NYSE:VSI) will unveil its latest earnings on Wednesday, October 26, 2011. Vitamin Shoppe is a retailer and direct marketer of vitamins, minerals, herbs, supplements, sports nutrition and other health and wellness products.

Vitamin Shoppe Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 33 cents per share, a rise of 22.2% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 44.3% versus last year to $1.53.

Past Earnings Performance: The company is looking to top estimates for the third straight quarter. Last quarter, it reported profit of 40 cents per share against a mean estimate of net income of 38 cents, and the quarter before, the company exceeded forecasts by 9 cents with profit of 49 cents versus a mean estimate of net income of 40 cents.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: On average, analysts predict $208.1 million in revenue this quarter, a rise of 11.1% from the year ago quarter. Analysts are forecasting total revenue of $851.8 million for the year, a rise of 13.4% from last year’s revenue of $751.5 million.

Analyst Ratings: Analysts are bullish on this stock with seven analysts rating it as a buy, none rating it as a sell and two rating it as a hold.

A Look Back: In the second quarter, profit rose 63.5% to $12 million (40 cents a share) from $7.3 million (26 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 12.3% to $215.9 million from $192.2 million.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 11.9%, with the biggest boost coming in the first quarter when revenue rose 13.2% from the year earlier quarter.

The company has seen net income rise in three straight quarters. Net income rose 32.8% in the first quarter and more than threefold in the fourth quarter of the last fiscal year.

Competitors to Watch:, Inc. (NASDAQ:VITC), CVS (NYSE:CVS),, inc. (NASDAQ:DSCM), China Nepstar Chain Drugstore Ltd. (NYSE:NPD), Graymark Healthcare Inc (NASDAQ:GRMH), Rite Aid Corporation (NYSE:RAD), PetMed Express, Inc. (NASDAQ:PETS), Sally Beauty Hldgs., Inc. (NYSE:SBH), Wal-Mart (NYSE:WMT), Target (NYSE:TGT), Walgreen Company (NYSE:WAG), and Perfumania Holdings, Inc. (NASDAQ:PERF).

Stock Price Performance: During July 27, 2011 to October 20, 2011, the stock price had fallen $5.28 (-12.3%) from $42.97 to $37.69. The stock price saw one of its best stretches over the last year between December 1, 2010 and December 10, 2010 when shares rose for eight-straight days, rising 15.2% (+$4.45) over that span. It saw one of its worst periods between March 9, 2011 and March 18, 2011 when shares fell for eight-straight days, falling 4.9% (-$1.66) over that span. Shares are up $4.05 (+12%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.